Drug
MitoQ (mitoquinol mesylate)
MitoQ (mitoquinol mesylate) is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Terminated(1)
Detailed Status
Recruiting1
Not yet recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
recruiting133%
not_yet_recruiting133%
terminated133%
Recent Activity
1 active trials
Showing 3 of 3
terminatedphase_2
Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome
NCT06351683
not_yet_recruitingnot_applicable
Role of Endothelial Dysfunction on Exercise Pressor Reflex in Type 2 Diabetes
NCT07228208
recruitingnot_applicable
WinQ : a Window of Opportunity Study With MitoQ in Breast Cancer
NCT07142096
Clinical Trials (3)
Showing 3 of 3 trials
NCT06351683Phase 2
Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome
NCT07228208Not Applicable
Role of Endothelial Dysfunction on Exercise Pressor Reflex in Type 2 Diabetes
NCT07142096Not Applicable
WinQ : a Window of Opportunity Study With MitoQ in Breast Cancer
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3